Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

CQP

Cheniere Energy Partners LP

Apr 19 • 03:47PM ET

49.15

Dollar change +0.41
Percentage change 0.84	%

Energy • Oil & Gas Midstream • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Index	-	P/E	7.02	EPS (ttm)	7.00	Insider Own	91.82%	Shs Outstand	484.00M	Perf Week	5.25%
Market Cap	23.79B	Forward P/E	11.93	EPS next Y	4.12	Insider Trans	0.00%	Shs Float	39.61M	Perf Month	-2.19%
Income	3.39B	PEG	-	EPS next Q	0.97	Inst Own	46.47%	Short Float	1.76%	Perf Quarter	-2.04%
Sales	9.66B	P/S	2.46	EPS this Y	-45.23%	Inst Trans	-0.29%	Short Ratio	3.51	Perf Half Y	-10.41%
Book/sh	2.14	P/B	22.92	EPS next Y	8.28%	ROA	17.97%	Short Interest	0.70M	Perf Year	8.12%
Cash/sh	1.30	P/C	37.70	EPS next 5Y	-7.70%	ROE	-	52W Range	42.80 - 62.02	Perf YTD	-0.78%
Dividend Est.	3.31 (6.73%)	P/FCF	8.23	EPS past 5Y	97.79%	ROI	20.26%	52W High	-20.76%	Beta	0.67
Dividend TTM	3.08 (6.26%)	Quick Ratio	0.92	Sales past 5Y	18.21%	Gross Margin	47.80%	52W Low	14.83%	ATR (14)	1.09
Dividend Ex-Date	Feb 06, 2024	Current Ratio	1.01	EPS Y/Y TTM	115.51%	Oper. Margin	46.70%	RSI (14)	54.95	Volatility	2.58% 2.12%
Employees	1605	Debt/Eq	15.42	Sales Y/Y TTM	-43.30%	Profit Margin	35.08%	Recom	3.86	Target Price	50.17
Option/Short	Yes / Yes	LT Debt/Eq	15.12	EPS Q/Q	-69.77%	Payout	59.39%	Rel Volume	0.95	Prev Close	48.74
Sales Surprise	8.66%	EPS Surprise	62.17%	Sales Q/Q	-43.11%	Earnings	Feb 22 BMO	Avg Volume	198.50K	Price	49.15
SMA20	1.53%	SMA50	-0.23%	SMA200	-5.52%	Trades		Volume	181,981	Change	0.84%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-22-24	Upgrade	Stifel	Sell → Hold
Nov-03-23	Downgrade	Stifel	Hold → Sell	$53
Oct-06-23	Resumed	Goldman	Sell	$48
Jul-19-23	Upgrade	UBS	Neutral → Buy	$57
Jun-01-23	Downgrade	Wolfe Research	Peer Perform → Underperform	$43
Dec-09-22	Initiated	Citigroup	Sell	$47
Aug-11-22	Upgrade	Evercore ISI	In-line → Outperform	$54 → $55
May-31-22	Downgrade	Wells Fargo	Equal Weight → Underweight	$55
Feb-01-22	Downgrade	UBS	Buy → Neutral	$50
Jan-14-22	Downgrade	Goldman	Buy → Neutral	$45
Nov-30-21	Downgrade	Barclays	Equal Weight → Underweight	$48
Jul-20-21	Downgrade	Barclays	Overweight → Equal Weight	$45
Jun-14-21	Upgrade	Goldman	Neutral → Buy	$56
Mar-12-21	Downgrade	JP Morgan	Neutral → Underweight	$44
Nov-19-20	Downgrade	Credit Suisse	Neutral → Underperform	$31 → $32
Oct-20-20	Initiated	Wells Fargo	Equal Weight
Aug-26-20	Downgrade	Citigroup	Buy → Neutral	$49 → $40
Jun-09-20	Downgrade	BMO Capital Markets	Market Perform → Underperform	$34
Mar-24-20	Upgrade	Barclays	Equal Weight → Overweight	$31
Mar-12-20	Upgrade	Credit Suisse	Underperform → Neutral

Show Previous Ratings

Apr-05-24 08:00AM	Cheniere Announces Timing of First Quarter 2024 Earnings Release and Conference Call (Business Wire)
Mar-28-24 04:30PM	Cheniere Energy Partners, L.P. 2023 Annual Report (Business Wire)
Feb-23-24 06:55PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Feb-22-24 04:43PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
07:30AM	Cheniere Partners Reports Fourth Quarter and Full Year 2023 Results and Introduces Full Year 2024 Distribution Guidance (Business Wire)
08:30AM	Loading…
Jan-31-24 08:30AM	Cheniere Announces Uplisting to the New York Stock Exchange (Business Wire)
Jan-26-24 05:14PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
08:30AM	Cheniere Partners Declares Quarterly Distributions (Business Wire)
Dec-12-23 07:18PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Nov-29-23 08:30AM	Cheniere Announces Long-Term Integrated Production Marketing Agreement with ARC Resources (Business Wire)
Nov-17-23 07:15PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Nov-02-23 03:38PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
07:30AM	Cheniere Partners Reports Third Quarter 2023 Results and Reconfirms 2023 Distribution Guidance (Business Wire)
Oct-27-23 04:05PM	Cheniere Partners Declares Quarterly Distributions (Business Wire)
Sep-29-23 02:11PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
05:11PM	Loading…
Sep-26-23 05:11PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Sep-18-23 11:05AM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Sep-07-23 01:44PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Aug-03-23 02:47PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
07:30AM	Cheniere Partners Reports Second Quarter 2023 Results and Reconfirms 2023 Distribution Guidance (Business Wire)
Jul-28-23 08:30AM	Cheniere Partners Declares Quarterly Distributions (Business Wire)
Jul-13-23 06:57PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Jun-06-23 04:08PM	Cheniere Partners Announces Pricing of $1.4 Billion Senior Notes due 2033 (Business Wire)
08:13AM	Cheniere Partners Announces Offering of Senior Notes due 2033 (Business Wire)
May-02-23 07:07PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
07:30AM	Cheniere Partners Reports First Quarter 2023 Results and Reconfirms 2023 Distribution Guidance (Business Wire)
Apr-28-23 08:00AM	Cheniere Partners Declares Quarterly Distributions (Business Wire)
Mar-15-23 07:17PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research) -5.88%
Mar-01-23 07:01PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Feb-24-23 04:01PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
11:36PM	Loading…
Feb-23-23 11:36PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research) +7.07%
07:30AM	Cheniere Partners Reports Fourth Quarter and Full Year 2022 Results and Introduces Full Year 2023 Distribution Guidance (Business Wire)
07:15AM	Cheniere Initiates Permitting Process for Significant Expansion of LNG Export Capacity at Sabine Pass (Business Wire)
Jan-27-23 08:00AM	Cheniere Partners Declares Quarterly Distributions (Business Wire)
Jan-05-23 12:05PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Jan-03-23 07:07PM	Analyst Report: Cheniere Energy Partners, L.P. (Morningstar Research)
Dec-14-22 09:00AM	Is Trending Stock Cheniere Energy, Inc. (LNG) a Buy Now? (Zacks)
Dec-12-22 04:24PM	Natural Gas Prices Spike As Winter Cold Arrives (Investor's Business Daily)
Dec-09-22 02:51PM	UPDATE 1-U.S. natgas futures jump 5% on colder forecasts for late December (Reuters)
09:11AM	U.S. natgas futures jump 6% on colder forecasts for late December (Reuters)
Dec-08-22 11:30AM	W&T (WTI) Down 18.1% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-05-22 08:20AM	Dow Jones Futures Fall In Resilient Market Rally; Tesla Stock Falls On Production Cut (Investor's Business Daily)
07:13AM	Dow Jones Futures Fall, Oil Prices Pop In Resilient Market Rally; Tesla Falls On Production Cut (Investor's Business Daily)
Dec-04-22 07:00PM	U.S. LNG Is Booming, But Who Supplies The Gas? (Oilprice.com)
Dec-02-22 05:08PM	Market Rally Resilient, But This Battle Continues; What To Do Now (Investor's Business Daily)
02:10PM	11 Best Commodity Stocks To Buy Now (Insider Monkey)
Nov-30-22 08:00AM	LNG Transporter Pipes In Breakout On Cheniere Energy Deal (Investor's Business Daily)
Nov-29-22 06:19PM	3 Must-Own Energy Stocks Before Winter Arrives (InvestorPlace)
09:00AM	Cheniere Energy, Inc. (LNG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
07:23AM	Fortinet and Light & Wonder have been highlighted as Zacks Bull and Bear of the Day (Zacks)
Nov-28-22 07:40AM	Natural Gas Spikes Above $7 After First Draw of the Season (Zacks)
Nov-26-22 01:41PM	7 Energy Stocks You Can Count On in This Uncertain Market (InvestorPlace)
Nov-24-22 07:00PM	Japan Believes An LNG Supply Squeeze Is Looming (Oilprice.com)
09:28AM	Heres Why Cheniere Energy (LNG) Outperformed in the Third Quarter (Insider Monkey)
08:52AM	Enbridge (ENB) Begins Operation in France Offshore Wind Farm (Zacks)
Nov-23-22 05:00PM	European Gas Market To Remain Tight Until At Least 2024 (Oilprice.com)
Nov-22-22 09:47AM	The Zacks Analyst Blog Highlights Cheniere energy, EQT and Comstock Resources (Zacks) +6.26%
Nov-21-22 08:31AM	Freezing Weather Pushes Up Heating Demand, Natural Gas Price (Zacks)
Nov-18-22 11:32AM	Cheniere (LNG) Q3 Earnings Beat on Elevated Prices & Demand (Zacks)
10:36AM	UPDATE 2-U.S. natgas eases 1% as Freeport LNG targets December restart (Reuters)
09:41AM	Cheniere Partners (CQP) Shares Dip 6.6% Since Q3 Earnings Miss (Zacks)
09:29AM	U.S. natural gas futures fall 4% with less cold weather coming (Reuters)
09:00AM	Cheniere Energy, Inc. (LNG) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
Nov-17-22 12:19PM	UPDATE 2-U.S. natural gas futures gain 3% on cold forecasts (Reuters)
09:02AM	U.S. natural gas futures gain 3% ahead of storage report (Reuters)
07:40AM	LNG Stock Golar Tops Earnings Views Amid Strong LNG Tanker Demand (Investor's Business Daily)
Nov-16-22 05:20PM	Excelerate Energy Stock Sets Up After Two Failed Breakouts (Investor's Business Daily)
03:41PM	UPDATE 1-U.S. natgas futures gain 3% on colder midday weather forecast (Reuters)
12:45PM	Here is Why Growth Investors Should Buy Cheniere Energy (LNG) Now (Zacks)
11:20AM	UPDATE 1-Texas Freeport LNG restart delay causes vessels to seek other ports (Reuters)
09:54AM	U.S. natgas falls 4% on less cold forecasts, Freeport LNG delay (Reuters)
09:38AM	Texas Freeport LNG restart delay causes vessels to seek other ports (Reuters)
Nov-15-22 03:03PM	UPDATE 1-U.S. natgas up 2% on colder forecasts; Freeport LNG delay (Reuters)
10:50AM	Race Is On to Be the Next Big US Supplier of LNG to Fuel-Starved Europe (Bloomberg)
09:49AM	U.S. natgas up 1% on colder weather forecasts; Freeport LNG delay expected (Reuters)
Nov-14-22 04:57PM	Cheniere Partners Announces Pricing of $430 Million Senior Secured Amortizing Notes due 2037 by Sabine Pass Liquefaction, LLC (Business Wire)
02:54PM	UPDATE 1-Freeport LNG to miss restart target for fire-damaged Texas export plant (Reuters)
01:08PM	UPDATE 2-U.S. natgas up 1% after paring gains on Texas Freeport LNG delay rumors (Reuters)
01:08PM	UPDATE 1-U.S. natgas futures pare gains on Texas Freeport LNG delay rumors (Reuters)
08:56AM	U.S. natgas futures jump 6% in volatile trade on colder forecasts (Reuters)
08:19AM	Cheniere Partners Announces Offering of Senior Secured Amortizing Notes due 2037 by Sabine Pass Liquefaction, LLC (Business Wire)
07:41AM	Time to Invest in These 4 Value Stocks With High Earnings Yield (Zacks)
Nov-12-22 07:30AM	3 Investing Megatrends You Can't Afford to Miss (Motley Fool)
Nov-11-22 11:36AM	UPDATE 1-U.S. natgas drops 6% on less cold weather, focus on Freeport LNG (Reuters)
10:00AM	China's Covid Saga Sends Oil Prices Spiking Again (Oilprice.com)
08:44AM	U.S. natgas futures steady as market balances cold forecasts (Reuters)
Nov-10-22 10:40PM	These 2 Strong Buy Energy Stocks Have Crushed the Market in 2022 And They Can Go Even Higher (TipRanks)
12:05PM	UPDATE 2-U.S. natgas jumps 6% on smaller-than-expected storage build, cold weather (Reuters)
09:02AM	U.S. natgas rises 2% on cold weather forecasts; storage report awaited (Reuters)
Nov-09-22 07:00PM	EU Leaders Accuse U.S. Natural Gas Producers Of Profiteering (Oilprice.com)
Nov-08-22 05:08PM	Goldman Sachs Energy Stocks: Top 10 Stock Picks (Insider Monkey)
03:55PM	Exclusive-Cheniere seeks 18 months to upgrade LNG turbines that failed pollution tests-document (Reuters)
11:10AM	7 No-Brainer Energy Stocks to Buy for 2023 and Beyond (InvestorPlace)
09:15AM	W&T Offshore, Inc. (WTI) Hit a 52 Week High, Can the Run Continue? (Zacks)
Nov-07-22 11:00PM	US and EU argue over claims of gas crisis profiteering (Financial Times)
05:05PM	Cheniere cleared to return Louisiana Sabine LNG tank after 2018 leak (Reuters)
12:20PM	3 Oil & Energy Stocks Still Poised for Growth (Zacks)
09:54AM	Dow Jones Rises 100 Points, But Apple Falls On iPhone Warning (Investor's Business Daily)
09:00AM	Cheniere Energy, Inc. (LNG) is Attracting Investor Attention: Here is What You Should Know (Zacks)
Nov-05-22 08:00AM	Albemarle, Arista Lead 5 Stocks Near Buy Points Without This Big Risk (Investor's Business Daily)

Cheniere Energy Partners LP engages in the operations of liquefied natural gas. The company was founded in 2006 and is headquartered in Houston, TX.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Grindal Corey	EVP & Chief Operating Officer	May 25 '23	Sale	45.93	7,649	351,304	0	May 26 05:18 PM

Open in Screener

CRL

Charles River Laboratories International Inc.

Apr 19 • 03:47PM ET

226.81

Dollar change -0.74
Percentage change -0.33	%

Healthcare • Diagnostics & Research • USA • NYSE

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

CRL Charles River Laboratories International Inc. daily Stock Chart

Held by: VTI VB VOO VBK IVV RSP IBB VHT IWR SCHM

Index	S&P 500	P/E	24.63	EPS (ttm)	9.21	Insider Own	2.14%	Shs Outstand	51.34M	Perf Week	-6.02%
Market Cap	11.65B	Forward P/E	18.23	EPS next Y	12.44	Insider Trans	-2.89%	Shs Float	50.25M	Perf Month	-15.42%
Income	474.62M	PEG	2.68	EPS next Q	2.06	Inst Own	101.39%	Short Float	3.15%	Perf Quarter	6.97%
Sales	4.13B	P/S	2.82	EPS this Y	3.35%	Inst Trans	3.21%	Short Ratio	2.94	Perf Half Y	22.49%
Book/sh	70.06	P/B	3.24	EPS next Y	12.82%	ROA	6.01%	Short Interest	1.58M	Perf Year	11.80%
Cash/sh	5.50	P/C	41.22	EPS next 5Y	9.19%	ROE	14.44%	52W Range	161.65 - 275.00	Perf YTD	-4.06%
Dividend Est.	-	P/FCF	31.88	EPS past 5Y	14.84%	ROI	7.12%	52W High	-17.52%	Beta	1.44
Dividend TTM	-	Quick Ratio	1.16	Sales past 5Y	12.89%	Gross Margin	33.56%	52W Low	40.31%	ATR (14)	6.82
Dividend Ex-Date	-	Current Ratio	1.52	EPS Y/Y TTM	-3.17%	Oper. Margin	15.82%	RSI (14)	26.54	Volatility	3.15% 2.49%
Employees	21800	Debt/Eq	0.87	Sales Y/Y TTM	3.86%	Profit Margin	11.49%	Recom	1.94	Target Price	271.56
Option/Short	Yes / Yes	LT Debt/Eq	0.85	EPS Q/Q	-0.65%	Payout	0.00%	Rel Volume	0.51	Prev Close	227.55
Sales Surprise	2.24%	EPS Surprise	2.42%	Sales Q/Q	-7.85%	Earnings	Feb 14 BMO	Avg Volume	538.99K	Price	226.81
SMA20	-10.78%	SMA50	-10.02%	SMA200	5.13%	Trades		Volume	265,113	Change	-0.33%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-15-24	Downgrade	Guggenheim	Buy → Neutral
Sep-13-23	Initiated	TD Cowen	Market Perform	$212
Jul-10-23	Downgrade	Citigroup	Buy → Neutral	$260 → $225
Feb-23-23	Upgrade	Guggenheim	Neutral → Buy	$255
Jan-12-23	Downgrade	Jefferies	Buy → Hold
Sep-30-22	Upgrade	Jefferies	Hold → Buy	$240
Aug-25-22	Initiated	Credit Suisse	Outperform	$285
Aug-04-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$350 → $250
May-24-22	Initiated	Guggenheim	Neutral
Apr-25-22	Downgrade	Jefferies	Buy → Hold	$370 → $280
Apr-07-22	Initiated	Stephens	Overweight	$377
Feb-17-22	Upgrade	Citigroup	Neutral → Buy	$400
Feb-17-22	Reiterated	UBS	Buy	$465 → $420
Feb-17-22	Reiterated	Morgan Stanley	Overweight	$465 → $430
Feb-17-22	Reiterated	Deutsche Bank	Buy	$409 → $350
Feb-17-22	Reiterated	BofA Securities	Buy	$445 → $400
Aug-05-21	Resumed	Credit Suisse	Neutral	$385
Dec-16-20	Downgrade	Citigroup	Buy → Neutral	$270 → $250
Sep-10-20	Upgrade	Jefferies	Hold → Buy	$254
Jul-01-20	Upgrade	BofA Securities	Neutral → Buy	$192

Show Previous Ratings

Apr-18-24 12:09PM	Notice to Long-Term Charles River Laboratories International, Inc. (CRL) Shareholders: Grabar Law Office Is Investigating Claims on Your Behalf (Newsfile)
Apr-16-24 11:50AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
08:00AM	Charles River Laboratories Launches Alternative Methods Advancement Project to Reduce Reliance on Animal Testing (Business Wire)
Apr-12-24 08:00AM	Charles River Laboratories Schedules First-Quarter 2024 Earnings Release and Conference Call (Business Wire)
Apr-11-24 09:10AM	Charles River (CRL) Forges Collaboration With Ship of Theseus (Zacks)
08:00AM	Loading…
08:00AM	Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology (Business Wire)
Apr-09-24 08:00AM	Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics (Business Wire)
Apr-04-24 08:00AM	Charles River to Perform Plasmid Production for Ship of Theseus (Business Wire)
Apr-01-24 08:00AM	Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024 (Business Wire)
Mar-27-24 08:00AM	Charles River Laboratories Publishes 2023 Corporate Citizenship Report (Business Wire)
Mar-26-24 09:39AM	Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine (Zacks)
Mar-23-24 09:00AM	U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies (The Wall Street Journal)
Mar-21-24 08:00AM	Charles River Announces Extension of Gene Therapy Manufacturing Alliance with NUS Yong Loo Lin School of Medicine (Business Wire)
Mar-15-24 11:30AM	Why Is Charles River (CRL) Up 6.2% Since Last Earnings Report? (Zacks)
10:30AM	Charles River (CRL) Extends Gene Therapy Offering With New Pact (Zacks)
09:46AM	Loading…
Mar-14-24 09:46AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
08:00AM	Charles River and Navega Therapeutics Announce Comprehensive Gene Therapy Manufacturing Collaboration (Business Wire)
Mar-12-24 08:00AM	Charles River Laboratories to Present at Barclays Global Healthcare Conference (Business Wire)
12:11AM	Insider Sell: CSVP & Chief Accounting Officer Michael Knell Sells Shares of Charles River ... (GuruFocus.com)
Mar-07-24 12:27PM	The Top 3 Healthcare Stocks to Buy in March 2024 (InvestorPlace)
Mar-01-24 11:32PM	Insider Sell: EVP & Chief People Officer Victoria Creamer Sells 5,000 Shares of Charles ... (GuruFocus.com)
Feb-29-24 02:00AM	Wheeler Bio Seals Agreement with Charles River to Offer Portable CMC to Discovery Clients to Accelerate Their Journey to First-in-Human Use (PR Newswire)
Feb-26-24 08:41AM	Charles River (CRL) Forges Collaboration With Wheeler Bio (Zacks)
Feb-21-24 10:40AM	Charles River (CRL) Gains From CRADL Amid Soft Market Scenario (Zacks)
08:00AM	Charles River and Wheeler Bio Complete Agreement to Accelerate the Journey from Discovery and CMC Development to Manufacturing (Business Wire)
Feb-20-24 01:15PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
08:08AM	Charles River Collaborates with Pluristyx, Expanding its Portfolio of Human Pluripotent Stem Cells (Business Wire)
Feb-15-24 01:00PM	The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldnt Ignore. (InvestorPlace)
10:54AM	Charles River Laboratories International, Inc. (NYSE:CRL) Q4 2023 Earnings Call Transcript (Insider Monkey)
12:38AM	Decoding Charles River Laboratories International Inc (CRL): A Strategic SWOT Insight (GuruFocus.com)
08:06PM	Loading…
Feb-14-24 08:06PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) +11.30%
09:30AM	Charles River (CRL) Reports Q4 Earnings: What Key Metrics Have to Say (Zacks)
09:30AM	Charles River (CRL) Q4 Earnings Surpass, Margins Contract (Zacks)
08:09AM	Charles River forecasts strong full-year profit on boost from Noveprim purchase (Reuters)
07:19AM	Charles River: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Fourth Quarter and Full-Year 2023 Results and Provides 2024 Guidance (Business Wire)
Feb-13-24 08:20AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
Feb-09-24 09:15AM	Unveiling Charles River (CRL) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
Feb-01-24 10:08AM	Charles River (CRL) to Report Q4 Earnings: What's in Store? (Zacks)
Jan-29-24 08:00AM	Charles River Introduces the First Rapid Animal-Free Bacterial Endotoxin Test (Business Wire)
Jan-27-24 09:00AM	Big Pharmas great lab monkey shortage: A crackdown on smuggling is causing chaos in Americas vital drug development pipeline (Fortune)
Jan-24-24 04:30PM	Charles River Laboratories Adds Reshema Kemps-Polanco to Board of Directors (Business Wire)
Jan-23-24 04:30PM	Charles River Laboratories Schedules Fourth-Quarter 2023 Earnings and 2024 Guidance Release and Conference Call (Business Wire)
Jan-18-24 09:10AM	Charles River's (CRL) New Launch to Boost Gene Therapy Programs (Zacks)
Jan-16-24 08:00AM	Ten Big Losers To Start The Year. Tesla Isn't The Worst. (Investor's Business Daily)
08:00AM	Charles River Launches Rep/Cap Plasmids to Streamline Adeno-Associated Viral Vector Manufacturing (Business Wire)
Jan-12-24 02:02PM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
09:00AM	10 Narrow Moat Stocks Hedge Funds Are Buying (Insider Monkey)
Jan-08-24 08:00AM	Charles River Laboratories to Present at J.P. Morgan Healthcare Conference (Business Wire)
Jan-02-24 09:00AM	How One Texas County Is Fighting 43,000 Monkeys (The Wall Street Journal)
Dec-19-23 08:01AM	Charles River's (CRL) Memphis Site Achieves Crucial Approval (Zacks)
Dec-18-23 08:00AM	Charles River and Vertex Pharmaceuticals Reach Important Milestone in Cell Therapy Manufacturing Collaboration (Business Wire)
Dec-13-23 08:29AM	Charles River (CRL) Expands 3D In Vitro Services Via New Deal (Zacks)
Dec-12-23 08:00AM	Charles River Finalizes Agreement with CELLphenomics, Expanding 3D In Vitro Services for Cancer Therapy Drug Screening (Business Wire)
Dec-08-23 11:30AM	Charles River (CRL) Up 19.7% Since Last Earnings Report: Can It Continue? (Zacks)
Dec-07-23 01:53PM	Investing in the Aging Population: 3 Healthcare Stocks to Watch (InvestorPlace)
Dec-05-23 07:29AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
Dec-02-23 01:05AM	Insider Sell: EVP Joseph Laplume Sells Shares of Charles River Laboratories International Inc (CRL) (GuruFocus.com)
Nov-29-23 07:57AM	Charles River (CRL) Backs the Quest to Cure SPG56 via New Deal (Zacks)
Nov-28-23 08:00AM	Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration (Business Wire)
Nov-27-23 08:30AM	Charles River Laboratories to Present at Evercore ISI Investor Conference (Business Wire)
Nov-22-23 03:04AM	Insider Buying: Corporate Executive VP & COO Birgit Girshick Acquires Shares of Charles ... (GuruFocus.com)
Nov-20-23 08:34PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
Nov-17-23 06:45PM	The 3 Most Undervalued Tech Stocks to Buy Now: November 2023 (InvestorPlace)
08:40AM	Charles River (CRL) Widens CliniPrime GMP Suite With New Launch (Zacks)
Nov-16-23 12:59PM	Hedge Fund and Insider Trading News: Ray Dalio, David Einhorn, Ken Griffin, Stanley Druckenmiller, David Tepper, RXO, Inc. (RXO), Charles River Laboratories International (CRL), and More (Insider Monkey)
08:00AM	Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products (Business Wire)
Nov-13-23 09:04AM	Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology (PR Newswire)
Nov-10-23 12:11PM	Charles River Laboratories International, Inc. (NYSE:CRL) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 05:14PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research)
08:00AM	Charles River Laboratories Industry Experts to Present Advanced Modalities at Neuroscience 2023 (Business Wire)
01:33AM	Q3 2023 Charles River Laboratories International Inc Earnings Call (Thomson Reuters StreetEvents)
Nov-08-23 03:20PM	Charles River Laboratories Posts Mixed Q3 Results; Updates 2023 Outlook (GuruFocus.com)
10:59AM	Charles River's (CRL) Q3 Earnings Beat, Margins Decline (Zacks)
09:30AM	Charles River (CRL) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
08:54AM	Charles River beats quarterly profit estimates, trims full-year revenue growth (Reuters)
08:26AM	Charles River Laboratories Narrows FY23 Outlook Range; Q3 Results Top Estimates (RTT News)
07:06AM	Charles River: Q3 Earnings Snapshot (Associated Press Finance)
07:00AM	Charles River Laboratories Announces Third-Quarter 2023 Results (Business Wire)
Nov-06-23 10:27AM	Unlocking Q3 Potential of Charles River (CRL): Exploring Wall Street Estimates for Key Metrics (Zacks)
Nov-01-23 10:01AM	Earnings Preview: Charles River Laboratories (CRL) Q3 Earnings Expected to Decline (Zacks)
09:13AM	Charles River (CRL) to Report Q3 Earnings: What's in Store? (Zacks)
Oct-25-23 08:06PM	Analyst Report: Charles River Laboratories International, Inc. (Morningstar Research) -5.97%
Oct-24-23 12:10PM	Why Charles River (CRL) Could Beat Earnings Estimates Again (Zacks)
Oct-23-23 10:10AM	Charles River (CRL) Offers Access to Preclinical Cancer Research (Zacks)
Oct-19-23 08:00AM	Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business (Business Wire)
Oct-16-23 08:30AM	Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call (Business Wire)
08:00AM	Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research (Business Wire)
Oct-11-23 08:00AM	Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals (Business Wire)
Oct-10-23 09:10AM	Here's Why You Should Retain Charles River (CRL) Stock Now (Zacks)
Oct-05-23 12:55PM	Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar (InvestorPlace)
Oct-02-23 11:35AM	Charles River (CRL) Launches LVV-based Gene Therapy Platform (Zacks)
Sep-27-23 12:04PM	Unveiling the Investment Potential of Charles River Laboratories International Inc (CRL): A ... (GuruFocus.com)
Sep-26-23 08:02AM	Charles River (CRL) Opens a RightSource Lab in Stevenage (Zacks)
08:00AM	Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing (Business Wire)
Sep-25-23 11:40AM	Unveiling Charles River Laboratories International's Value: Is It Really Priced Right? A ... (GuruFocus.com)
08:00AM	Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster (Business Wire)
Sep-21-23 11:36AM	Unveiling Charles River Laboratories International (CRL)'s Value: Is It Really Priced Right? A ... (GuruFocus.com) -5.02%
Sep-20-23 08:30AM	Charles River Laboratories to Host Virtual Investor Day (Business Wire)
Sep-18-23 12:03PM	Unpacking the Investment Potential of Charles River Laboratories International Inc (CRL): A ... (GuruFocus.com)

Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Mar 08 '24	Sale	267.52	808	216,156	7,024	Mar 11 04:42 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Mar 04 '24	Sale	261.05	2,750	717,890	7,832	Mar 05 04:54 PM
Creamer Victoria L	EVP & Chief People Officer	Feb 29 '24	Sale	253.70	5,000	1,268,500	13,550	Mar 01 05:37 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Feb 29 '24	Sale	253.45	3,786	959,545	4,792	Mar 04 04:09 PM
Barbo William D	Corporate Executive VP & CCO	Feb 22 '24	Sale	248.50	4,050	1,006,425	22,879	Feb 23 04:57 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Feb 15 '24	Option Exercise	144.67	5,882	850,949	8,478	Feb 20 05:32 PM
Parisotto Shannon M	CEVP, Disc & Safety Assessment	Feb 15 '24	Sale	241.20	5,882	1,418,767	2,596	Feb 20 05:32 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Feb 15 '24	Sale	238.93	838	200,223	24,620	Feb 20 05:20 PM
FOSTER JAMES C	Chairman, President and CEO	Jan 29 '24	Option Exercise	144.67	17,436	2,522,466	227,827	Jan 31 04:59 PM
Girshick Birgit	Corporate Executive VP & COO	Jan 10 '24	Option Exercise	215.19	5,916	1,273,064	50,365	Jan 11 04:09 PM
Creamer Victoria L	EVP & Chief People Officer	Dec 14 '23	Option Exercise	136.70	5,526	755,388	22,032	Dec 18 04:07 PM
Creamer Victoria L	EVP & Chief People Officer	Dec 14 '23	Sale	225.00	5,526	1,243,350	16,506	Dec 18 04:07 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 30 '23	Sale	197.73	1,850	365,800	23,133	Dec 01 04:10 PM
Girshick Birgit	Corporate Executive VP & COO	Nov 20 '23	Buy	187.82	1,322	248,298	44,449	Nov 21 05:07 PM
FOSTER JAMES C	Chairman, President and CEO	Nov 14 '23	Buy	178.05	5,620	1,000,641	202,643	Nov 15 09:23 AM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 09 '23	Option Exercise	144.67	9,128	1,320,548	34,111	Nov 13 04:12 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Nov 09 '23	Sale	173.48	9,128	1,583,522	24,983	Nov 13 04:12 PM
WALLMAN RICHARD F	Director	Aug 24 '23	Buy	198.79	1,000	198,786	1,000	Aug 29 04:23 PM
Barbo William D	Corporate Executive VP & CCO	Aug 10 '23	Option Exercise	144.67	5,511	797,276	9,103	Aug 14 04:17 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 10 '23	Option Exercise	144.67	1,471	212,810	11,411	Aug 14 04:15 PM
Barbo William D	Corporate Executive VP & CCO	Aug 10 '23	Sale	217.24	5,763	1,251,954	3,592	Aug 14 04:17 PM
Knell Michael Gunnar	CSVP&Chief Accounting Officer	Aug 10 '23	Sale	216.54	1,471	318,530	9,940	Aug 14 04:15 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	Aug 10 '23	Sale	216.52	700	151,564	24,983	Aug 14 04:11 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 15 '23	Sale	190.39	345	65,685	24,026	May 16 02:18 PM
LaPlume Joseph W	EVP, Corp Strategy & Develop	May 12 '23	Sale	193.03	959	185,116	24,371	May 15 02:49 PM
MASSARO GEORGE	Director	May 11 '23	Sale	193.43	288	55,708	4,964	May 15 02:42 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CQP

Cheniere Energy Partners LP

CRL

Charles River Laboratories International Inc.

Upgrade your FINVIZ experience